Paul Thomas
CIK 1166776 · President and CEO · last filed 2026-06-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VITA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BRANCHBURG, NJ 08876
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AXGN | Director | 32,395 | $38.02 | $1.23M | -$633.7K | 12 | 2026-06-26 |
| TELA | Director | 23,600 | $0.98 | $23.2K | $0 | 1 | 2026-06-11 |
| ABIOMED INC (ABMD) Delisted | Director | 6,357 | $381.02 | $2.42M | -$3.42M | 13 | 2022-11-03 |
| SURGALIGN HOLDINGS, INC. (SRGA) Delisted | Director | 28,610 | $0.18 | $5.2K | $0 | 3 | 2022-08-17 |
| RTI SURGICAL, INC. (RTIX) Delisted | Director | 0 | — | — | $0 | 5 | 2019-03-11 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Director | 0 | — | — | $0 | 6 | 2016-11-30 |
| Roka BioScience, Inc. (ROKA) Delisted | President and CEO | 85,494 | — | — | $0 | 4 | 2016-11-10 |
| ABIOMED INC (APOL) Delisted | Director | 22,932 | — | — | -$2.60M | 11 | 2016-08-11 |
| KINETIC CONCEPTS INC (KCI) Delisted | President, LifeCell Corp. | 0 | — | — | $0 | 1 | 2008-08-27 |
| LIFECELL CORP (VITA) Delisted | Chairman, President and CEO | 0 | — | — | -$8.66M | 10 | 2008-06-04 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 38,931 | — | — | $0 | 1 | 2007-03-05 |
Recent Filings · Page 3 of 8
75 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-10 | SURGALIGN HOLDINGS, INC. (SRGA) Delisted | Grant (A) | +57,803 | $0 | EDGAR |
| 2020-10-02 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2020-08-14 | ABIOMED INC (ABMD) Delisted | Grant (A) | +661 | $0 | EDGAR |
| 2020-08-11 | ABIOMED INC (ABMD) Delisted | Mixed | −2,390 | -$729.7K | EDGAR |
| 2020-03-04 | ABIOMED INC (ABMD) Delisted | Sell (S) | −2,000 | -$303.6K | EDGAR |
| 2020-03-02 | — | Grant (A) | +24,692 | $0 | |
| 2020-02-12 | ABIOMED INC (ABMD) Delisted | Sell (S) | −2,000 | -$362.3K | EDGAR |
| 2019-08-09 | ABIOMED INC (ABMD) Delisted | Mixed | +808 | -$46.5K | EDGAR |
| 2019-03-11 | — | Grant (A) | +75,723 | $0 | |
| 2019-03-11 | RTI SURGICAL, INC. (RTIX) Delisted | Disp (D) | −75,723 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.